You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Cellular therapies
96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Pankov D, Eleftheriadou I, Domogala A, et al
96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0096